Skip to content

Joint Consultation Between a Neurologist and a Clinical Psychologist

Evaluation of a Joint Consultation Between a Neurologist and a Clinical Psychologist, Dedicated to Neurodegenerative and/or Neurogenetic Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05394974
Acronym
JOCONDE
Enrollment
200
Registered
2022-05-27
Start date
2021-06-01
Completion date
2023-06-01
Last updated
2022-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative Disorders

Keywords

Joint neurologist, psychologist consultation, neurodegenerative and/or neurogenetic disease

Brief summary

Joint consultations appeared a few years ago in routine medical practice, but they are still not widely used and rarely evaluated. The primary purpose of the study is to evaluate the impact for the patient of the presence of a clinical psychologist during the joint consultation. The secondary purpose is to evaluate the impact for the patient and for the neurologist of the presence of a clinical psychologist during the joint consultation

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patient with a neurodegenerative and/or neurogenetic disease * adult patient

Exclusion criteria

* dementia * age \<18 years

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfaction after the consultation assessed by 3 questions on a Likert scaleAfter consultation et 1 to 3 months later5-point Likert scale from which to select a response : 1. Very satisfied. 2. Moderately satisfied. 3. Neither satisfied nor dissatisfied. 4. Moderately dissatisfied. 5. Very dissatisfied.

Countries

France

Contacts

Primary ContactMathieu ANHEIM, MD, PhD
mathieu.anheim@chru-strasbourg.fr+33 3 88 12 85 35

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026